taimed biologics inc (4147:Taiwan)
taimed biologics inc (4147) Snapshot
|
Open
71.41
|
Previous Close
71.41
|
|
|
Day High
71.74
|
Day Low
70.00
|
|
|
52 Week High
02/23/13 - 94.49
|
52 Week Low
04/17/13 - 22.52
|
|
|
Market Cap
13.5B
|
Average Volume 10 Days
514.8K
|
|
|
EPS TTM
--
|
Shares Outstanding
193.1M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
taimed biologics inc (4147) Related Businessweek News
No Related Businessweek News Foundtaimed biologics inc (4147) Details
TaiMed Biologics, Inc., a biotechnology company, engages in the discovery, development, and delivery of medicines primarily for HIV/AIDS in Taiwan. Its products pipeline include TMB-355, a phase IIb viral-entry inhibitor that blocks humanized mAb to treat HIV/AIDS; TMB-358, which is a preclinical stage development medicine that retains the anti-HIV activity of the parent molecule; and Tamiphosphor, a small molecule inhibitor of influenza virus neuraminidase. The company was founded in 2007 and is based in Taipei, Taiwan.
| Recently Viewed | |||
| 4147:TT | 70.00 TWD | -1.41 |  |
| Company | Last | Change | |
| No competitor information is available for 4147. | |||
| View Industry Companies | |||
Industry Analysis
4147
Industry Average
| Valuation | 4147 | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 21.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact TAIMED BIOLOGICS INC, please visit www.taimedbiologics.com.tw. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
